SARS-CoV-2 and interferon blockade #MMPMID33167852
Diamond B; Volpe BT; VanPatten S; Al Abed Y
Mol Med 2020[Nov]; 26 (1): 103 PMID33167852show ga
The response to viral infection generally includes an activation of the adaptive immune response to produce cytotoxic T cells and neutralizing antibodies. We propose that SARS-CoV-2 activates the innate immune system through the renin-angiotensin and kallikrein-bradykinin pathways, blocks interferon production and reduces an effective adaptive immune response. This model has therapeutic implications.